Esperion Completes Patient Enrollment in Global Pivotal Phase 3 Program for Bempedoic Acid
October 2, 2017Pivotal Phase 3 Top-Line Results for Bempedoic Acid Expected in the Second and Third Quarters of 2018
More »
FierceBiotech's 2017 Fierce 15
September 26, 2017Axial Biotherapeutics selected in FierceBiotech's 2017 Fierce 15
More »
IntegenX Applauds the Passage of the Rapid DNA Act of 2017
August 21, 2017Amendment of the DNA Identification Act of 1994 is a substantial step forward in making real-time DNA testing of arrestees in the booking environment a reality
More »